Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study. The Impact of Treatment and Other Baseline Factors

Ophthalmology

Volumn 116, Issue 2, 2009, Pages

  Musch, David C ^a   Gillespie, Brenda W ^a   Lichter, Paul R ^a   Niziol, Leslie M ^a   Janz, Nancy K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; ANTIDIABETIC AGENT; ANTIGLAUCOMA AGENT;

ADULT; AGED; ARGON LASER; ARTICLE; CATARACT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; INTRAOCULAR PRESSURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL TREATMENT; TRABECULECTOMY; VISUAL FIELD; VISUAL FIELD DEFECT;

EID: 58849133280     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.08.051     Document Type: Article

References (29)

1. Smith R.J. Medical versus surgical therapy in glaucoma simplex. Br J Ophthalmol 56 (1972) 277-283
2. Watson P.G., and Grierson I. The place of trabeculectomy in the treatment of glaucoma. Ophthalmology 88 (1981) 175-196
3. Jay J.L., and Murray S.B. Early trabeculectomy versus conventional management in primary open angle glaucoma. Br J Ophthalmol 72 (1988) 881-889
4. Migdal C., Gregory W., and Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 101 (1994) 1651-1656 ; discussion 1657
5. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 (2000) 429-440
6. Burr J., Azuara-Blanco A., and Avenell A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev 2 (2005) CD004399
7. Musch D.C., Lichter P.R., Guire K.E., et al., CIGTS Study Group. The Collaborative Initial Glaucoma Treatment Study (CIGTS): study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 106 (1999) 653-662
8. Lichter P.R., Musch D.C., Gillespie B.W., et al., CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108 (2001) 1943-1953
9. Gillespie B.W., Musch D.C., Guire K.E., et al., CIGTS Study Group. The Collaborative Initial Glaucoma Treatment Study: baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci 44 (2003) 2613-2620
10. Laird N.M., and Ware J.H. Random-effects models for longitudinal data. Biometrics 38 (1982) 963-974
11. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
12. Musch D.C., Gillespie B.W., Niziol L.M., et al., Collaborative Initial Glaucoma Treatment Study (CIGTS) Group. Cataract extraction in the Collaborative Initial Glaucoma Treatment Study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch Ophthalmol 124 (2006) 1694-1700
13. Nouri-Mahdavi K., Hoffman D., Coleman A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111 (2004) 1627-1635
14. Leske M.C., Heijl A., Hussein M., et al., Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 121 (2003) 48-56
15. Leske M.C., Heijl A., Hyman L., et al., EMGT Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology 114 (2007) 1965-1972
16. Drance S., Anderson D.R., Schulzer M., and Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131 (2001) 699-708
17. Werner E.B., Drance S.M., and Schulzer M. Trabeculectomy and the progression of glaucomatous visual field loss. Arch Ophthalmol 95 (1977) 1374-1377
18. O'Brien C., Schwartz B., Takamoto T., and Wu D.C. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol 111 (1991) 491-500
19. Vogel R., Crick R.P., Newson R.B., et al. Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br J Ophthalmol 74 (1990) 3-6
20. Stewart W.C., Chorak R.P., Hunt H.H., and Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol 116 (1993) 176-181
21. Stewart W.C., Kolker A.E., Sharpe E.D., et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol 130 (2000) 274-279
22. Konstas A.G., Topouzis F., Leliopoulou O., et al. 24-hour intraocular pressure control with maximal medical therapy compared with surgery in patients with advanced open-angle glaucoma. Ophthalmology 113 (2006) 761-765
23. Kass M.A., Gordon M., and Meltzer D.W. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?. Am J Ophthalmol 101 (1986) 524-530
24. Kass M.A., Gordon M., Morley Jr. R.E., et al. Compliance with topical timolol treatment. Am J Ophthalmol 103 (1987) 188-193
25. Edmunds B., Bunce C.V., Thompson J.R., et al. Factors associated with success in first-time trabeculectomy for patients at low risk of failure with chronic open-angle glaucoma. Ophthalmology 111 (2004) 97-103
26. Hugkulstone C.E., Smith L.F., and Vernon S.A. Trabeculectomy in diabetic patients with glaucoma. Eye 7 (1993) 502-506
27. Shin D.H., Hughes B.A., Song M.S., et al. Primary glaucoma triple procedure with or without adjunctive mitomycin: prognostic factors for filtration failure. Ophthalmology 103 (1996) 1925-1933
28. Lee P.P., Walt J.W., Rosenblatt L.C., et al. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol 144 (2007) 901-907
29. Siam G.A., de Barros D.S., Gheith M.E., et al. The amount of intraocular pressure rise during pharmacological pupillary dilatation is an indicator of the likelihood of future progression of glaucoma. Br J Ophthalmol 91 (2007) 1170-1172